Reference
FDA warns patients and health care providers about potential risks associated with compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders Internet Document : 10 Oct 2023. Available from: URL: https://www.fda.gov/drugs/human-drug-compounding/fda-warns-patients-and-health-care-providers-about-potential-risks-associated-compounded-ketamine
Rights and permissions
About this article
Cite this article
Compounded ketamine products: potential risks of at-home use. Reactions Weekly 1979, 2 (2023). https://doi.org/10.1007/s40278-023-47729-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-47729-y